ロード中...
Pathological complete response and residual DCIS following neoadjuvant chemotherapy for breast carcinoma
Patients who have no residual invasive cancer following neoadjuvant chemotherapy for breast carcinoma have a better overall survival than those with residual disease. Many classification systems assessing pathological response to neoadjuvant chemotherapy include residual ductal carcinoma in situ (DC...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2361141/ https://ncbi.nlm.nih.gov/pubmed/16421590 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602950 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|